869 reports of this reaction
3.9% of all CARBOXYMETHYLCELLULOSE SODIUM reports
#4 most reported adverse reaction
EYE IRRITATION is the #4 most commonly reported adverse reaction for CARBOXYMETHYLCELLULOSE SODIUM, manufactured by Allergan, Inc.. There are 869 FDA adverse event reports linking CARBOXYMETHYLCELLULOSE SODIUM to EYE IRRITATION. This represents approximately 3.9% of all 22,264 adverse event reports for this drug.
Patients taking CARBOXYMETHYLCELLULOSE SODIUM who experience eye irritation should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
EYE IRRITATION is moderately reported among CARBOXYMETHYLCELLULOSE SODIUM users, representing a notable but not dominant share of adverse events.
In addition to eye irritation, the following adverse reactions have been reported for CARBOXYMETHYLCELLULOSE SODIUM:
The following drugs have also been linked to eye irritation in FDA adverse event reports:
EYE IRRITATION has been reported as an adverse event in 869 FDA reports for CARBOXYMETHYLCELLULOSE SODIUM. This does not prove causation, but indicates an association observed in post-market surveillance data.
EYE IRRITATION accounts for approximately 3.9% of all adverse event reports for CARBOXYMETHYLCELLULOSE SODIUM, making it a notable side effect.
If you experience eye irritation while taking CARBOXYMETHYLCELLULOSE SODIUM, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.